We investigated the potency of two different strategies for reversing the myopathology of dysferlin deficiency: overexpression of myoferlin and AAV-mediated transfer of a minidysferlin. The gene discussed is MYOF; the disease is hyperinsulinemic hypoglycemia, familial, 4.